Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

about

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

Item

http://www.wikidata.org/entity/Q57064977

description

scientific article published on 29 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@en

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@nl

type

Item

label

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@en

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@nl

prefLabel

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@en

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@nl

P1476

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

@en

P2093

A I M Hoepelman

http://www.w3.org/2001/XMLSchema#string

A Urbanus

http://www.w3.org/2001/XMLSchema#string

E A Croes

http://www.w3.org/2001/XMLSchema#string

J A Willemse

http://www.w3.org/2001/XMLSchema#string

J E Arends

http://www.w3.org/2001/XMLSchema#string

K J van Erpecum

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe

Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data.

Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands.

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.

Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting.

P2888

s41124-018-0040-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S41124-018-0040-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patricia A M Kracht

P577

2018-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107317117

http://www.w3.org/2001/XMLSchema#string

P698

30288334

http://www.w3.org/2001/XMLSchema#string

P932

6162944

http://www.w3.org/2001/XMLSchema#string